Publication | Open Access
A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study
156
Citations
17
References
2016
Year
MUC5AC is a valuable diagnostic biomarker, either alone or in combination with CA19-9, to differentiate PC from CP and benign controls.
| Year | Citations | |
|---|---|---|
Page 1
Page 1